mRNA Vaccines & Therapeutics Industry Research Report 2023
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
Highlights
The global mRNA Vaccines & Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by mRNA Vaccines & Therapeutics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the mRNA Vaccines & Therapeutics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
mRNA Vaccines & Therapeutics segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the mRNA Vaccines & Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the mRNA Vaccines & Therapeutics market.
mRNA Vaccines & Therapeutics segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the mRNA Vaccines & Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the mRNA Vaccines & Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of mRNA Vaccines & Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global mRNA Vaccines & Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global core mRNA vaccines & therapeutics manufacturers include Moderna Therapeutics, CureVac etc. The top 3 companies hold a share about 65%. Europe is the largest market, with a share about 10%, followed by Asia Pacific and North America.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccines & Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccines & Therapeutics.
The mRNA Vaccines & Therapeutics market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccines & Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccines & Therapeutics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
Global markets are presented by mRNA Vaccines & Therapeutics type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the mRNA Vaccines & Therapeutics are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
mRNA Vaccines & Therapeutics segment by Type
- Infectious Disease Vaccines
- Cancer Vaccines
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the mRNA Vaccines & Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the mRNA Vaccines & Therapeutics market.
mRNA Vaccines & Therapeutics segment by Application
- Infectious Disease
- Cancer
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the mRNA Vaccines & Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Vaccines & Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of mRNA Vaccines & Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the mRNA Vaccines & Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Vaccines & Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of mRNA Vaccines & Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of mRNA Vaccines & Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of mRNA Vaccines & Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global mRNA Vaccines & Therapeutics Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global mRNA Vaccines & Therapeutics Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2018-2023)
Table 8. Global mRNA Vaccines & Therapeutics Revenue of Manufacturers (2018-2023)
Table 9. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market mRNA Vaccines & Therapeutics Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global mRNA Vaccines & Therapeutics Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Vaccines & Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Moderna Therapeutics Company Information
Table 17. Moderna Therapeutics Business Overview
Table 18. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 20. Moderna Therapeutics Recent Developments
Table 21. CureVac Company Information
Table 22. CureVac Business Overview
Table 23. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. CureVac mRNA Vaccines & Therapeutics Product Portfolio
Table 25. CureVac Recent Developments
Table 26. Translate Bio Company Information
Table 27. Translate Bio Business Overview
Table 28. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
Table 30. Translate Bio Recent Developments
Table 31. BioNTech Company Information
Table 32. BioNTech Business Overview
Table 33. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. BioNTech mRNA Vaccines & Therapeutics Product Portfolio
Table 35. BioNTech Recent Developments
Table 36. Sangamo Therapeutics Company Information
Table 37. Sangamo Therapeutics Business Overview
Table 38. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 40. Sangamo Therapeutics Recent Developments
Table 41. Argos Therapeutics Company Information
Table 42. Argos Therapeutics Business Overview
Table 43. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 45. Argos Therapeutics Recent Developments
Table 46. In-Cell-Art Company Information
Table 47. In-Cell-Art Business Overview
Table 48. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
Table 50. In-Cell-Art Recent Developments
Table 51. eTheRNA Company Information
Table 52. eTheRNA Business Overview
Table 53. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
Table 55. eTheRNA Recent Developments
Table 56. Ethris Company Information
Table 57. Ethris Business Overview
Table 58. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. Ethris mRNA Vaccines & Therapeutics Product Portfolio
Table 60. Ethris Recent Developments
Table 61. Tiba Biotechnology Company Information
Table 62. Tiba Biotechnology Business Overview
Table 63. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 64. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
Table 65. Tiba Biotechnology Recent Developments
Table 66. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Global mRNA Vaccines & Therapeutics Sales by Region (2018-2023) & (M Doses)
Table 68. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2018-2023)
Table 69. Global mRNA Vaccines & Therapeutics Sales by Region (2024-2029) & (M Doses)
Table 70. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2024-2029)
Table 71. Global mRNA Vaccines & Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 72. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2018-2023)
Table 73. Global mRNA Vaccines & Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 74. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2024-2029)
Table 75. North America mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. North America mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 77. North America mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 78. North America mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 79. North America mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 80. Europe mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Europe mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 82. Europe mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 83. Europe mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 85. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 87. Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 88. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 89. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 90. Latin America mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Latin America mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 92. Latin America mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 93. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 94. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 95. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 97. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 98. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 99. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 100. Global mRNA Vaccines & Therapeutics Sales by Type (2018-2023) & (M Doses)
Table 101. Global mRNA Vaccines & Therapeutics Sales by Type (2024-2029) & (M Doses)
Table 102. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2023)
Table 103. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2024-2029)
Table 104. Global mRNA Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 105. Global mRNA Vaccines & Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 106. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2023)
Table 107. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2024-2029)
Table 108. Global mRNA Vaccines & Therapeutics Price by Type (2018-2023) & (USD/Doses)
Table 109. Global mRNA Vaccines & Therapeutics Price by Type (2024-2029) & (USD/Doses)
Table 110. Global mRNA Vaccines & Therapeutics Sales by Application (2018-2023) & (M Doses)
Table 111. Global mRNA Vaccines & Therapeutics Sales by Application (2024-2029) & (M Doses)
Table 112. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2023)
Table 113. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2024-2029)
Table 114. Global mRNA Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 115. Global mRNA Vaccines & Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 116. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2023)
Table 117. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2024-2029)
Table 118. Global mRNA Vaccines & Therapeutics Price by Application (2018-2023) & (USD/Doses)
Table 119. Global mRNA Vaccines & Therapeutics Price by Application (2024-2029) & (USD/Doses)
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. mRNA Vaccines & Therapeutics Distributors List
Table 123. mRNA Vaccines & Therapeutics Customers List
Table 124. mRNA Vaccines & Therapeutics Industry Trends
Table 125. mRNA Vaccines & Therapeutics Industry Drivers
Table 126. mRNA Vaccines & Therapeutics Industry Restraints
Table 127. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global mRNA Vaccines & Therapeutics Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global mRNA Vaccines & Therapeutics Sales (M Doses) of Manufacturers (2018-2023)
Table 7. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturers (2018-2023)
Table 8. Global mRNA Vaccines & Therapeutics Revenue of Manufacturers (2018-2023)
Table 9. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market mRNA Vaccines & Therapeutics Average Price (USD/Doses) of Manufacturers (2018-2023)
Table 11. Global mRNA Vaccines & Therapeutics Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of mRNA Vaccines & Therapeutics, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Vaccines & Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Moderna Therapeutics Company Information
Table 17. Moderna Therapeutics Business Overview
Table 18. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 19. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 20. Moderna Therapeutics Recent Developments
Table 21. CureVac Company Information
Table 22. CureVac Business Overview
Table 23. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 24. CureVac mRNA Vaccines & Therapeutics Product Portfolio
Table 25. CureVac Recent Developments
Table 26. Translate Bio Company Information
Table 27. Translate Bio Business Overview
Table 28. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 29. Translate Bio mRNA Vaccines & Therapeutics Product Portfolio
Table 30. Translate Bio Recent Developments
Table 31. BioNTech Company Information
Table 32. BioNTech Business Overview
Table 33. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 34. BioNTech mRNA Vaccines & Therapeutics Product Portfolio
Table 35. BioNTech Recent Developments
Table 36. Sangamo Therapeutics Company Information
Table 37. Sangamo Therapeutics Business Overview
Table 38. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 39. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 40. Sangamo Therapeutics Recent Developments
Table 41. Argos Therapeutics Company Information
Table 42. Argos Therapeutics Business Overview
Table 43. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 44. Argos Therapeutics mRNA Vaccines & Therapeutics Product Portfolio
Table 45. Argos Therapeutics Recent Developments
Table 46. In-Cell-Art Company Information
Table 47. In-Cell-Art Business Overview
Table 48. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 49. In-Cell-Art mRNA Vaccines & Therapeutics Product Portfolio
Table 50. In-Cell-Art Recent Developments
Table 51. eTheRNA Company Information
Table 52. eTheRNA Business Overview
Table 53. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 54. eTheRNA mRNA Vaccines & Therapeutics Product Portfolio
Table 55. eTheRNA Recent Developments
Table 56. Ethris Company Information
Table 57. Ethris Business Overview
Table 58. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 59. Ethris mRNA Vaccines & Therapeutics Product Portfolio
Table 60. Ethris Recent Developments
Table 61. Tiba Biotechnology Company Information
Table 62. Tiba Biotechnology Business Overview
Table 63. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)
Table 64. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Portfolio
Table 65. Tiba Biotechnology Recent Developments
Table 66. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Global mRNA Vaccines & Therapeutics Sales by Region (2018-2023) & (M Doses)
Table 68. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2018-2023)
Table 69. Global mRNA Vaccines & Therapeutics Sales by Region (2024-2029) & (M Doses)
Table 70. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2024-2029)
Table 71. Global mRNA Vaccines & Therapeutics Revenue by Region (2018-2023) & (US$ Million)
Table 72. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2018-2023)
Table 73. Global mRNA Vaccines & Therapeutics Revenue by Region (2024-2029) & (US$ Million)
Table 74. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2024-2029)
Table 75. North America mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. North America mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 77. North America mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 78. North America mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 79. North America mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 80. Europe mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Europe mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 82. Europe mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 83. Europe mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 84. Europe mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 85. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 87. Asia Pacific mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 88. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 89. Asia Pacific mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 90. Latin America mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Latin America mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 92. Latin America mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 93. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 94. Latin America mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 95. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2018-2023) & (M Doses)
Table 97. Middle East and Africa mRNA Vaccines & Therapeutics Sales by Country (2024-2029) & (M Doses)
Table 98. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2018-2023) & (US$ Million)
Table 99. Middle East and Africa mRNA Vaccines & Therapeutics Revenue by Country (2024-2029) & (US$ Million)
Table 100. Global mRNA Vaccines & Therapeutics Sales by Type (2018-2023) & (M Doses)
Table 101. Global mRNA Vaccines & Therapeutics Sales by Type (2024-2029) & (M Doses)
Table 102. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2023)
Table 103. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2024-2029)
Table 104. Global mRNA Vaccines & Therapeutics Revenue by Type (2018-2023) & (US$ Million)
Table 105. Global mRNA Vaccines & Therapeutics Revenue by Type (2024-2029) & (US$ Million)
Table 106. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2023)
Table 107. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2024-2029)
Table 108. Global mRNA Vaccines & Therapeutics Price by Type (2018-2023) & (USD/Doses)
Table 109. Global mRNA Vaccines & Therapeutics Price by Type (2024-2029) & (USD/Doses)
Table 110. Global mRNA Vaccines & Therapeutics Sales by Application (2018-2023) & (M Doses)
Table 111. Global mRNA Vaccines & Therapeutics Sales by Application (2024-2029) & (M Doses)
Table 112. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2023)
Table 113. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2024-2029)
Table 114. Global mRNA Vaccines & Therapeutics Revenue by Application (2018-2023) & (US$ Million)
Table 115. Global mRNA Vaccines & Therapeutics Revenue by Application (2024-2029) & (US$ Million)
Table 116. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2023)
Table 117. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2024-2029)
Table 118. Global mRNA Vaccines & Therapeutics Price by Application (2018-2023) & (USD/Doses)
Table 119. Global mRNA Vaccines & Therapeutics Price by Application (2024-2029) & (USD/Doses)
Table 120. Key Raw Materials
Table 121. Raw Materials Key Suppliers
Table 122. mRNA Vaccines & Therapeutics Distributors List
Table 123. mRNA Vaccines & Therapeutics Customers List
Table 124. mRNA Vaccines & Therapeutics Industry Trends
Table 125. mRNA Vaccines & Therapeutics Industry Drivers
Table 126. mRNA Vaccines & Therapeutics Industry Restraints
Table 127. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. mRNA Vaccines & TherapeuticsProduct Picture
Figure 5. Global mRNA Vaccines & Therapeutics Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global mRNA Vaccines & Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 7. Global mRNA Vaccines & Therapeutics Sales (2018-2029) & (M Doses)
Figure 8. Global mRNA Vaccines & Therapeutics Average Price (USD/Doses) & (2018-2029)
Figure 9. Infectious Disease Vaccines Product Picture
Figure 10. Cancer Vaccines Product Picture
Figure 11. Infectious Disease Product Picture
Figure 12. Cancer Product Picture
Figure 13. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 mRNA Vaccines & Therapeutics Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global mRNA Vaccines & Therapeutics Sales by Region in 2022
Figure 20. Global mRNA Vaccines & Therapeutics Revenue by Region in 2022
Figure 21. North America mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 22. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 23. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 24. United States mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 27. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 28. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 29. Germany mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 35. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 37. China mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 47. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 48. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 49. Mexico mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 53. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 55. Turkey mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2029)
Figure 59. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2029)
Figure 60. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2018-2029)
Figure 61. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2029)
Figure 62. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2029)
Figure 63. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2018-2029)
Figure 64. mRNA Vaccines & Therapeutics Value Chain
Figure 65. mRNA Vaccines & Therapeutics Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. mRNA Vaccines & TherapeuticsProduct Picture
Figure 5. Global mRNA Vaccines & Therapeutics Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global mRNA Vaccines & Therapeutics Market Size (2018-2029) & (US$ Million)
Figure 7. Global mRNA Vaccines & Therapeutics Sales (2018-2029) & (M Doses)
Figure 8. Global mRNA Vaccines & Therapeutics Average Price (USD/Doses) & (2018-2029)
Figure 9. Infectious Disease Vaccines Product Picture
Figure 10. Cancer Vaccines Product Picture
Figure 11. Infectious Disease Product Picture
Figure 12. Cancer Product Picture
Figure 13. Global mRNA Vaccines & Therapeutics Revenue Share by Manufacturers in 2022
Figure 14. Global Manufacturers of mRNA Vaccines & Therapeutics, Manufacturing Sites & Headquarters
Figure 15. Global Manufacturers of mRNA Vaccines & Therapeutics, Date of Enter into This Industry
Figure 16. Global Top 5 and 10 mRNA Vaccines & Therapeutics Players Market Share by Revenue in 2022
Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 18. Global mRNA Vaccines & Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 19. Global mRNA Vaccines & Therapeutics Sales by Region in 2022
Figure 20. Global mRNA Vaccines & Therapeutics Revenue by Region in 2022
Figure 21. North America mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 22. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 23. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 24. United States mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 27. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 28. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 29. Germany mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 35. Asia Pacific mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 36. Asia Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 37. China mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 47. Latin America mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 48. Latin America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 49. Mexico mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East and Africa mRNA Vaccines & Therapeutics Market Size by Country in 2022
Figure 53. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2018-2029)
Figure 54. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2018-2029)
Figure 55. Turkey mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. UAE mRNA Vaccines & Therapeutics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2018-2029)
Figure 59. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2018-2029)
Figure 60. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2018-2029)
Figure 61. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2018-2029)
Figure 62. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2018-2029)
Figure 63. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Application (2018-2029)
Figure 64. mRNA Vaccines & Therapeutics Value Chain
Figure 65. mRNA Vaccines & Therapeutics Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. mRNA Vaccines & Therapeutics Industry Opportunities and Challenges
